Bristol-Myers Squibb has completed its $7.8 billion acquisition of DuPont Pharmaceuticals of North Billerica, MA. New York City-based Bristol-Myers Squibb initiated the purchase as part of a growth strategy that emphasizes its medicines business, according to the firm. BMS expects the transaction will be accretive to its earnings per share in 2003.
By AuntMinnie.com staff writersOctober 4, 2001
Related Reading
DuPont's Definity echoes through contrast market, September 5, 2001
DuPont pharma divestiture could cast ripples in imaging, June 22, 2001
Bristol-Myers Squibb to buy DuPont Pharmaceuticals, June 12, 2001
DuPont closes in on fate of medical imaging business, April 9, 2001
Copyright © 2001 AuntMinnie.com
